Copyright Reports & Markets. All rights reserved.

Global Central Nervous System Therapy Market Insights, Forecast to 2028

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Central Nervous System Therapy Product Introduction
    • 1.2 Market by Type
      • 1.2.1 Global Central Nervous System Therapy Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
      • 1.2.2 Antidepressant Treatment
      • 1.2.3 Antipsychotic Therapy
      • 1.2.4 Other CNS Disorder
    • 1.3 Market by Application
      • 1.3.1 Global Central Nervous System Therapy Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
      • 1.3.2 Hospital
      • 1.3.3 Clinic
    • 1.4 Study Objectives
    • 1.5 Years Considered

    2 Executive Summary

    • 2.1 Global Central Nervous System Therapy Sales Estimates and Forecasts 2017-2028
    • 2.2 Global Central Nervous System Therapy Revenue Estimates and Forecasts 2017-2028
    • 2.3 Global Central Nervous System Therapy Revenue by Region: 2017 VS 2021 VS 2028
    • 2.4 Global Central Nervous System Therapy Sales by Region
      • 2.4.1 Global Central Nervous System Therapy Sales by Region (2017-2022)
      • 2.4.2 Global Sales Central Nervous System Therapy by Region (2023-2028)
    • 2.5 Global Central Nervous System Therapy Revenue by Region
      • 2.5.1 Global Central Nervous System Therapy Revenue by Region (2017-2022)
      • 2.5.2 Global Central Nervous System Therapy Revenue by Region (2023-2028)
    • 2.6 North America
    • 2.7 Europe
    • 2.8 Asia-Pacific
    • 2.9 Latin America
    • 2.10 Middle East & Africa

    3 Competition by Manufacturers

    • 3.1 Global Central Nervous System Therapy Sales by Manufacturers
      • 3.1.1 Global Top Central Nervous System Therapy Manufacturers by Sales (2017-2022)
      • 3.1.2 Global Central Nervous System Therapy Sales Market Share by Manufacturers (2017-2022)
      • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Central Nervous System Therapy in 2021
    • 3.2 Global Central Nervous System Therapy Revenue by Manufacturers
      • 3.2.1 Global Central Nervous System Therapy Revenue by Manufacturers (2017-2022)
      • 3.2.2 Global Central Nervous System Therapy Revenue Market Share by Manufacturers (2017-2022)
      • 3.2.3 Global Top 10 and Top 5 Companies by Central Nervous System Therapy Revenue in 2021
    • 3.3 Global Central Nervous System Therapy Sales Price by Manufacturers (2017-2022)
    • 3.4 Analysis of Competitive Landscape
      • 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
      • 3.4.2 Global Central Nervous System Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
      • 3.4.3 Global Central Nervous System Therapy Manufacturers Geographical Distribution
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Global Central Nervous System Therapy Sales by Type
      • 4.1.1 Global Central Nervous System Therapy Historical Sales by Type (2017-2022)
      • 4.1.2 Global Central Nervous System Therapy Forecasted Sales by Type (2023-2028)
      • 4.1.3 Global Central Nervous System Therapy Sales Market Share by Type (2017-2028)
    • 4.2 Global Central Nervous System Therapy Revenue by Type
      • 4.2.1 Global Central Nervous System Therapy Historical Revenue by Type (2017-2022)
      • 4.2.2 Global Central Nervous System Therapy Forecasted Revenue by Type (2023-2028)
      • 4.2.3 Global Central Nervous System Therapy Revenue Market Share by Type (2017-2028)
    • 4.3 Global Central Nervous System Therapy Price by Type
      • 4.3.1 Global Central Nervous System Therapy Price by Type (2017-2022)
      • 4.3.2 Global Central Nervous System Therapy Price Forecast by Type (2023-2028)

    5 Market Size by Application

    • 5.1 Global Central Nervous System Therapy Sales by Application
      • 5.1.1 Global Central Nervous System Therapy Historical Sales by Application (2017-2022)
      • 5.1.2 Global Central Nervous System Therapy Forecasted Sales by Application (2023-2028)
      • 5.1.3 Global Central Nervous System Therapy Sales Market Share by Application (2017-2028)
    • 5.2 Global Central Nervous System Therapy Revenue by Application
      • 5.2.1 Global Central Nervous System Therapy Historical Revenue by Application (2017-2022)
      • 5.2.2 Global Central Nervous System Therapy Forecasted Revenue by Application (2023-2028)
      • 5.2.3 Global Central Nervous System Therapy Revenue Market Share by Application (2017-2028)
    • 5.3 Global Central Nervous System Therapy Price by Application
      • 5.3.1 Global Central Nervous System Therapy Price by Application (2017-2022)
      • 5.3.2 Global Central Nervous System Therapy Price Forecast by Application (2023-2028)

    6 North America

    • 6.1 North America Central Nervous System Therapy Market Size by Type
      • 6.1.1 North America Central Nervous System Therapy Sales by Type (2017-2028)
      • 6.1.2 North America Central Nervous System Therapy Revenue by Type (2017-2028)
    • 6.2 North America Central Nervous System Therapy Market Size by Application
      • 6.2.1 North America Central Nervous System Therapy Sales by Application (2017-2028)
      • 6.2.2 North America Central Nervous System Therapy Revenue by Application (2017-2028)
    • 6.3 North America Central Nervous System Therapy Market Size by Country
      • 6.3.1 North America Central Nervous System Therapy Sales by Country (2017-2028)
      • 6.3.2 North America Central Nervous System Therapy Revenue by Country (2017-2028)
      • 6.3.3 United States
      • 6.3.4 Canada

    7 Europe

    • 7.1 Europe Central Nervous System Therapy Market Size by Type
      • 7.1.1 Europe Central Nervous System Therapy Sales by Type (2017-2028)
      • 7.1.2 Europe Central Nervous System Therapy Revenue by Type (2017-2028)
    • 7.2 Europe Central Nervous System Therapy Market Size by Application
      • 7.2.1 Europe Central Nervous System Therapy Sales by Application (2017-2028)
      • 7.2.2 Europe Central Nervous System Therapy Revenue by Application (2017-2028)
    • 7.3 Europe Central Nervous System Therapy Market Size by Country
      • 7.3.1 Europe Central Nervous System Therapy Sales by Country (2017-2028)
      • 7.3.2 Europe Central Nervous System Therapy Revenue by Country (2017-2028)
      • 7.3.3 Germany
      • 7.3.4 France
      • 7.3.5 U.K.
      • 7.3.6 Italy
      • 7.3.7 Russia

    8 Asia Pacific

    • 8.1 Asia Pacific Central Nervous System Therapy Market Size by Type
      • 8.1.1 Asia Pacific Central Nervous System Therapy Sales by Type (2017-2028)
      • 8.1.2 Asia Pacific Central Nervous System Therapy Revenue by Type (2017-2028)
    • 8.2 Asia Pacific Central Nervous System Therapy Market Size by Application
      • 8.2.1 Asia Pacific Central Nervous System Therapy Sales by Application (2017-2028)
      • 8.2.2 Asia Pacific Central Nervous System Therapy Revenue by Application (2017-2028)
    • 8.3 Asia Pacific Central Nervous System Therapy Market Size by Region
      • 8.3.1 Asia Pacific Central Nervous System Therapy Sales by Region (2017-2028)
      • 8.3.2 Asia Pacific Central Nervous System Therapy Revenue by Region (2017-2028)
      • 8.3.3 China
      • 8.3.4 Japan
      • 8.3.5 South Korea
      • 8.3.6 India
      • 8.3.7 Australia
      • 8.3.8 China Taiwan
      • 8.3.9 Indonesia
      • 8.3.10 Thailand
      • 8.3.11 Malaysia

    9 Latin America

    • 9.1 Latin America Central Nervous System Therapy Market Size by Type
      • 9.1.1 Latin America Central Nervous System Therapy Sales by Type (2017-2028)
      • 9.1.2 Latin America Central Nervous System Therapy Revenue by Type (2017-2028)
    • 9.2 Latin America Central Nervous System Therapy Market Size by Application
      • 9.2.1 Latin America Central Nervous System Therapy Sales by Application (2017-2028)
      • 9.2.2 Latin America Central Nervous System Therapy Revenue by Application (2017-2028)
    • 9.3 Latin America Central Nervous System Therapy Market Size by Country
      • 9.3.1 Latin America Central Nervous System Therapy Sales by Country (2017-2028)
      • 9.3.2 Latin America Central Nervous System Therapy Revenue by Country (2017-2028)
      • 9.3.3 Mexico
      • 9.3.4 Brazil
      • 9.3.5 Argentina
      • 9.3.6 Colombia

    10 Middle East and Africa

    • 10.1 Middle East and Africa Central Nervous System Therapy Market Size by Type
      • 10.1.1 Middle East and Africa Central Nervous System Therapy Sales by Type (2017-2028)
      • 10.1.2 Middle East and Africa Central Nervous System Therapy Revenue by Type (2017-2028)
    • 10.2 Middle East and Africa Central Nervous System Therapy Market Size by Application
      • 10.2.1 Middle East and Africa Central Nervous System Therapy Sales by Application (2017-2028)
      • 10.2.2 Middle East and Africa Central Nervous System Therapy Revenue by Application (2017-2028)
    • 10.3 Middle East and Africa Central Nervous System Therapy Market Size by Country
      • 10.3.1 Middle East and Africa Central Nervous System Therapy Sales by Country (2017-2028)
      • 10.3.2 Middle East and Africa Central Nervous System Therapy Revenue by Country (2017-2028)
      • 10.3.3 Turkey
      • 10.3.4 Saudi Arabia

    11 Company Profiles

    • 11.1 Abbvie
      • 11.1.1 Abbvie Corporation Information
      • 11.1.2 Abbvie Overview
      • 11.1.3 Abbvie Central Nervous System Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
      • 11.1.4 Abbvie Central Nervous System Therapy Product Model Numbers, Pictures, Descriptions and Specifications
      • 11.1.5 Abbvie Recent Developments
    • 11.2 Alkermes
      • 11.2.1 Alkermes Corporation Information
      • 11.2.2 Alkermes Overview
      • 11.2.3 Alkermes Central Nervous System Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
      • 11.2.4 Alkermes Central Nervous System Therapy Product Model Numbers, Pictures, Descriptions and Specifications
      • 11.2.5 Alkermes Recent Developments
    • 11.3 Allergan
      • 11.3.1 Allergan Corporation Information
      • 11.3.2 Allergan Overview
      • 11.3.3 Allergan Central Nervous System Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
      • 11.3.4 Allergan Central Nervous System Therapy Product Model Numbers, Pictures, Descriptions and Specifications
      • 11.3.5 Allergan Recent Developments
    • 11.4 AstraZeneca
      • 11.4.1 AstraZeneca Corporation Information
      • 11.4.2 AstraZeneca Overview
      • 11.4.3 AstraZeneca Central Nervous System Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
      • 11.4.4 AstraZeneca Central Nervous System Therapy Product Model Numbers, Pictures, Descriptions and Specifications
      • 11.4.5 AstraZeneca Recent Developments
    • 11.5 BIAL
      • 11.5.1 BIAL Corporation Information
      • 11.5.2 BIAL Overview
      • 11.5.3 BIAL Central Nervous System Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
      • 11.5.4 BIAL Central Nervous System Therapy Product Model Numbers, Pictures, Descriptions and Specifications
      • 11.5.5 BIAL Recent Developments
    • 11.6 Bristol-myers Squibb
      • 11.6.1 Bristol-myers Squibb Corporation Information
      • 11.6.2 Bristol-myers Squibb Overview
      • 11.6.3 Bristol-myers Squibb Central Nervous System Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
      • 11.6.4 Bristol-myers Squibb Central Nervous System Therapy Product Model Numbers, Pictures, Descriptions and Specifications
      • 11.6.5 Bristol-myers Squibb Recent Developments
    • 11.7 Eisai
      • 11.7.1 Eisai Corporation Information
      • 11.7.2 Eisai Overview
      • 11.7.3 Eisai Central Nervous System Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
      • 11.7.4 Eisai Central Nervous System Therapy Product Model Numbers, Pictures, Descriptions and Specifications
      • 11.7.5 Eisai Recent Developments
    • 11.8 Endo Pharmaceuticals
      • 11.8.1 Endo Pharmaceuticals Corporation Information
      • 11.8.2 Endo Pharmaceuticals Overview
      • 11.8.3 Endo Pharmaceuticals Central Nervous System Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
      • 11.8.4 Endo Pharmaceuticals Central Nervous System Therapy Product Model Numbers, Pictures, Descriptions and Specifications
      • 11.8.5 Endo Pharmaceuticals Recent Developments
    • 11.9 Eli Lilly and Company
      • 11.9.1 Eli Lilly and Company Corporation Information
      • 11.9.2 Eli Lilly and Company Overview
      • 11.9.3 Eli Lilly and Company Central Nervous System Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
      • 11.9.4 Eli Lilly and Company Central Nervous System Therapy Product Model Numbers, Pictures, Descriptions and Specifications
      • 11.9.5 Eli Lilly and Company Recent Developments
    • 11.10 Hoffmann-LA Roche
      • 11.10.1 Hoffmann-LA Roche Corporation Information
      • 11.10.2 Hoffmann-LA Roche Overview
      • 11.10.3 Hoffmann-LA Roche Central Nervous System Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
      • 11.10.4 Hoffmann-LA Roche Central Nervous System Therapy Product Model Numbers, Pictures, Descriptions and Specifications
      • 11.10.5 Hoffmann-LA Roche Recent Developments

    12 Industry Chain and Sales Channels Analysis

    • 12.1 Central Nervous System Therapy Industry Chain Analysis
    • 12.2 Central Nervous System Therapy Key Raw Materials
      • 12.2.1 Key Raw Materials
      • 12.2.2 Raw Materials Key Suppliers
    • 12.3 Central Nervous System Therapy Production Mode & Process
    • 12.4 Central Nervous System Therapy Sales and Marketing
      • 12.4.1 Central Nervous System Therapy Sales Channels
      • 12.4.2 Central Nervous System Therapy Distributors
    • 12.5 Central Nervous System Therapy Customers

    13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

    • 13.1 Central Nervous System Therapy Industry Trends
    • 13.2 Central Nervous System Therapy Market Drivers
    • 13.3 Central Nervous System Therapy Market Challenges
    • 13.4 Central Nervous System Therapy Market Restraints

    14 Key Findings in The Global Central Nervous System Therapy Study

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
        • 15.1.2 Data Source
      • 15.2 Author Details

      Summary:

      Market Analysis and Insights: Global Central Nervous System Therapy Market
      Due to the COVID-19 pandemic, the global Central Nervous System Therapy market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Antidepressant Treatment accounting for % of the Central Nervous System Therapy global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital segment is altered to an % CAGR throughout this forecast period.
      China Central Nervous System Therapy market size is valued at US$ million in 2021, while the US and Europe Central Nervous System Therapy are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Central Nervous System Therapy landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
      The global key manufacturers of Central Nervous System Therapy include Abbvie, Alkermes, Allergan, AstraZeneca, BIAL, Bristol-myers Squibb, Eisai, Endo Pharmaceuticals and Eli Lilly and Company and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
      Market Segments
      The authors of this research report have explored the key segments: Type and Application. The report offers an in-depth breakdown of type and application segments and their sub-segments. The lucrativeness and growth potential have been looked into by the industry experts in this report. This section of the report also provides sales and revenue forecast data by type and application segments based on sales, price, and revenue for the period 2017-2028. The specialists, to broaden the understanding of the users, have done value chain and raw material analysis in this section.
      Segment by Type
      Antidepressant Treatment
      Antipsychotic Therapy
      Other CNS Disorder
      Segment by Application
      Hospital
      Clinic
      Consequence of Covid-19 Pandemic
      The authors of this study have enlightened the readers on the rise and effect of the Covid-19 outbreak on the development. They have investigated the changes brought about in the demand/supply side, consumption, supply chain, and sales/manufacturing. The readers will get familiar with the measures that have helped the key players to bring the Central Nervous System Therapy market back to the pre-covid levels.
      Trends & Prospects
      In this segment of the report, the specialists have delved into the key growth opportunities that are likely to emerge. This will aid the key players to simplify complex issues related to business and frame future strategies to compete in this competitive environment. This section will certainly assist the players to boldly position their business.
      By Region
      North America
      United States
      Canada
      Europe
      Germany
      France
      U.K.
      Italy
      Russia
      Asia-Pacific
      China
      Japan
      South Korea
      India
      Australia
      China Taiwan
      Indonesia
      Thailand
      Malaysia
      Latin America
      Mexico
      Brazil
      Argentina
      Colombia
      Middle East & Africa
      Turkey
      Saudi Arabia
      UAE
      Competitive Outlook
      In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and share analysis of the prominent players are also provided in this section. They have also provided reliable sales and revenue data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
      Abbvie
      Alkermes
      Allergan
      AstraZeneca
      BIAL
      Bristol-myers Squibb
      Eisai
      Endo Pharmaceuticals
      Eli Lilly and Company
      Hoffmann-LA Roche
      Frequently Asked Questions
      Which is the most lucrative product segment in the Central Nervous System Therapy market?
      Which are the prominent strategies of the Central Nervous System Therapy market players?
      Which factors are increasing the competition in the Central Nervous System Therapy market?
      Which are the recommendations provided by the Central Nervous System Therapy industry experts?
      Which region will witness rewarding growth during the forecast period?
      What factors will curb the Central Nervous System Therapy market growth?
      Which product segment will register the fastest growth rate in the Central Nervous System Therapy market?
      Which emerging trends will impact the Central Nervous System Therapy market growth?
      Which are the high-impact rendering factors in the Central Nervous System Therapy market?
      Which companies will maintain their lead on the Central Nervous System Therapy market?
      Buy now